Heterocyclic compounds useful as RAF kinase inhibitors
US7968536B2 · kind B2 · utility
6Cited by
18References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 30, 2008 |
| Grant date | Jun 28, 2011 |
| Priority date | — |
| Expiry date | Jun 30, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds useful as inhibitors of protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.